Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melissa L Perreault

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
Neuroscience Letters|July 30, 2019
Asenapine maleate normalizes low frequency oscillatory deficits in a neurodevelopmental model of schizophreniaTapia Foute Nelong, Joshua D Manduca, Paula M Zonneveld, et al.
The International Journal of Neuropsychopharmacology|July 26, 2012
A physiological role for the dopamine D5 receptor as a regulator of BDNF and Akt signalling in rodent prefrontal cortexMelissa L Perreault, Jace Jones-Tabah, Brian F O'Dowd, et al.
Brain Sciences|September 28, 2021
Sex Differences in Dopamine Receptors and Relevance to Neuropsychiatric DisordersOlivia O F Williams, Madeleine Coppolino, Susan R George, et al.
The Canadian Journal of Addiction|September 18, 2020
EXTENDED ATTENUATION OF CORTICOSTRIATAL POWER AND COHERENCE AFTER ACUTE EXPOSURE TO VAPOURIZED Δ9 TETRAHYDROCANNABINOL IN RATSTapia Foute Nelong, Bryan W Jenkins, Melissa L Perreault, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 21, 2005
Kappa-opioid agonist U69593 potentiates locomotor sensitization to the D2/D3 agonist quinpirole: pre- and postsynaptic mechanismsMelissa L Perreault, Dawn Graham, Liane Bisnaire, et al.
Plos One|March 20, 2012
Dopamine D1-D2 receptor heteromer in dual phenotype GABA/glutamate-coexpressing striatal medium spiny neurons: regulation of BDNF, GAD67 and VGLUT1/2Melissa L Perreault, Theresa Fan, Mohammed Alijaniaram, et al.
Psychopharmacology|July 11, 2007
Cotreatment with the kappa opioid agonist U69593 enhances locomotor sensitization to the D2/D3 dopamine agonist quinpirole and alters dopamine D2 receptor and prodynorphin mRNA expression in ratsMelissa L Perreault, Dawn Graham, Sarah Scattolon, et al.
The European Journal of Neuroscience|July 6, 2017
The atypical dopamine receptor agonist SKF 83959 enhances hippocampal and prefrontal cortical neuronal network activity in a rat model of cognitive dysfunctionMelissa L Perreault, Theresa Fan, Tomek J Banasikowski, et al.
International Journal of Molecular Sciences|June 2, 2021
Sex-Specific Cannabidiol- and Iloperidone-Induced Neuronal Activity Changes in an In Vitro MAM Model System of SchizophreniaRachel-Karson Thériault, Myles St-Denis, Tristen Hewitt, et al.
Schizophrenia Research|April 21, 2024
Sex differences in neuronal oscillatory activity and memory in the methylazoxymethanol acetate model of schizophreniaAbdalla M Albeely, Olivia O F Williams, Colin R Blight, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Neuroscience Letters|July 30, 2019
Asenapine maleate normalizes low frequency oscillatory deficits in a neurodevelopmental model of schizophreniaTapia Foute Nelong, Joshua D Manduca, Paula M Zonneveld, et al.
The International Journal of Neuropsychopharmacology|July 26, 2012
A physiological role for the dopamine D5 receptor as a regulator of BDNF and Akt signalling in rodent prefrontal cortexMelissa L Perreault, Jace Jones-Tabah, Brian F O'Dowd, et al.
Brain Sciences|September 28, 2021
Sex Differences in Dopamine Receptors and Relevance to Neuropsychiatric DisordersOlivia O F Williams, Madeleine Coppolino, Susan R George, et al.
The Canadian Journal of Addiction|September 18, 2020
EXTENDED ATTENUATION OF CORTICOSTRIATAL POWER AND COHERENCE AFTER ACUTE EXPOSURE TO VAPOURIZED Δ9 TETRAHYDROCANNABINOL IN RATSTapia Foute Nelong, Bryan W Jenkins, Melissa L Perreault, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 21, 2005
Kappa-opioid agonist U69593 potentiates locomotor sensitization to the D2/D3 agonist quinpirole: pre- and postsynaptic mechanismsMelissa L Perreault, Dawn Graham, Liane Bisnaire, et al.
Plos One|March 20, 2012
Dopamine D1-D2 receptor heteromer in dual phenotype GABA/glutamate-coexpressing striatal medium spiny neurons: regulation of BDNF, GAD67 and VGLUT1/2Melissa L Perreault, Theresa Fan, Mohammed Alijaniaram, et al.
Psychopharmacology|July 11, 2007
Cotreatment with the kappa opioid agonist U69593 enhances locomotor sensitization to the D2/D3 dopamine agonist quinpirole and alters dopamine D2 receptor and prodynorphin mRNA expression in ratsMelissa L Perreault, Dawn Graham, Sarah Scattolon, et al.
The European Journal of Neuroscience|July 6, 2017
The atypical dopamine receptor agonist SKF 83959 enhances hippocampal and prefrontal cortical neuronal network activity in a rat model of cognitive dysfunctionMelissa L Perreault, Theresa Fan, Tomek J Banasikowski, et al.
International Journal of Molecular Sciences|June 2, 2021
Sex-Specific Cannabidiol- and Iloperidone-Induced Neuronal Activity Changes in an In Vitro MAM Model System of SchizophreniaRachel-Karson Thériault, Myles St-Denis, Tristen Hewitt, et al.
Schizophrenia Research|April 21, 2024
Sex differences in neuronal oscillatory activity and memory in the methylazoxymethanol acetate model of schizophreniaAbdalla M Albeely, Olivia O F Williams, Colin R Blight, et al.
Pageof 5